4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0001179110-18-011179
EVP & Chief Medical Officer sold 16,500 shares at $3.51 ($57,861)
- EVP & Chief Medical Officer acquired 16,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Duliege Anne-Marie · EVP & Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-04 | Exercise or conversion : show line 1 in the form | +16,500 | $2.54 | $41,910 | 16,500 | D |
| 2018-09-04 | Sale : show line 2 in the form | −16,500 | $3.51 | $57,861 | 0 | D |
| Open-market sales · 16,500 sh · avg $3.51 · $57,861 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-09-04 | Exercise or conversion : show line 3 in the form Employe Stock Option (right to buy) | −16,500 | $2.54 | 2026-05-05 | 16,500 | 383,500 | D |
Loading xslF345X03/edgar.xml…